MYC and Burkitt lymphoma: Figure 8B shows the proteins that were affected along with their functions and Figure 8A gives a comparison of their expressions with the control. C-myc is a marker for Burkitt’s lymphoma and is a regulator gene that codes for a transcription factor [79]. The protein is multi-functional playing roles in apoptotic inhibition and cell cycle progression. Treatment with LCCTLA reduced the expression of c-myc in a time-dependent manner as shown in Figure 8A. Similar results were also demonstrated by Edwards et al. [45].